Faculty Information - TOCHIMOTO Akiko

（Last updated : 2024-03-26 20:40:08）

TOCHIMOTO Akiko
Department School of Medicine(Tokyo Women's Medical University Hospital), School of Medicine Department of Internal Medicine, Division of Rheumatology

Position Assistant Professor

■ Published papers

1.	Original article	Association of elevated serum carbohydrate antigen 19-9 levels with extensive interstitial lung disease in patients with systemic sclerosis: A cross-sectional study 2023/11/20
2.	Original article	Antifibrotic effect of apremilast in systemic sclerosis dermal fibroblasts and bleomycin-induced mouse model 2023/11/08
3.	Original article	Characteristics of Japanese patients with systemic sclerosis complicated with calcinosis. 2021/04/28
4.	Original article	Antifibrotic effects of 2-carba cyclic phosphatidic acid (2ccPA) in systemic sclerosis: contribution to the novel treatment 2019/04
5.	Original article	Capillary abnormalities observed by nailfold video-capillaroscopy in Japanese patients with systemic sclerosis. 2018/11/01
6.	Original article	Sildenafil attenuates the fibrotic phenotype of skin fibroblasts in patients with systemic sclerosis. 2015/12
7.	Original article	Genetic Susceptibility to Interstitial Lung Disease Associated with Systemic Sclerosis. 2015
8.	Original article	Efficacy and safety of intravenous cyclophosphamide pulse therapy with oral prednisolone in the treatment of interstitial lung disease with systemic sclerosis: 4-year follow-up. 2011/06
9.	Original article	Single nucleotide polymorphisms of CD244 gene predispose to renal and neuropsychiatric manifestations with systemic lupus erythematosus. 2010/10
10.	Original article	Clinical manifestation and prognostic factor in anti-melanoma differentiation-associated gene 5 antibody-associated interstitial lung disease as a complication of dermatomyositis. 2010/09
Display 5 items
Display all(10)

■ Academic conference presentation

1.	Association study of IFIH1 gene polymorphisms in systemic sclerosis (SSc) 2022/04/25
2.	MPO-ANCA POSITIVITY IS RELATED TO INTERSTITIAL LUNG DISEASE IN SYSTEMIC SCLEROSIS 2018/06/15
3.	Apremilast Attenuates the Fibrogenic Phenotype of Dermal Fibroblasts from Patients with Systemic Sclerosis, Contributing to the Prevention of the Progression of Experimental Dermal Fibrosis 2016/11/16
4.	Cyclic phosphatidic acid suppresses fibroblast activity in systemic sclerosis 2016/04
5.	Association study of a Glutamate cystein ligase gene polymorphism with susceptibility to systemic sclerosis. 2016/02
6.	ASSOCIATION OF THE HYPOXIA-INDUCIBLE FACTOR 1A (HIF1ALPHA) GENE POLYMORPHISM IN JAPANESE SYSTEMIC SCLEROSIS (SSC) WITH THE PULMONARY ARTERIAL HYPERTENSION (PAH) 2015/06/13
7.	EARLY DETECTION AND TREATMENT FOR BORDERLINE PULMONARY ARTERIAL HYPERTENSION IN PATIENTS WITH SYSTEMIC SCLEROSIS IN JAPAN 2015/06/13
8.	Association of BTB and CNS homology 2 (BACH2) gene polymorphism with systemic sclerosis (SSc) in Japanese population. 2015/04/25
9.	Notch pathway is activated in Systemic Sclerosis (SSc). 2012/02
10.	Notch pathway is activated in Systemic Sclerosis (SSc) 2011/11
11.	Clinical manifestation and prognostic factor in anti-melanoma differentiation-associated gene 5 antibody-associated interstitial lung disease as a complication of dermatomyositis. 2010/11
12.	Activin-Smad pathway is activated in systemic sclerosis 2009/10
13.	Augmentation of IL-21 receptor by Endothelin-1 via Endothelin Receptor B in skin fibroblasts from systemic sclerosis 2009/10
14.	Increased ferritin predicts development and severity of acute interstitial lung disease as complication of dermatomyositis 2009/10
Display 5 items
Display all(14)